KLF5 and lung cancer: The network analysis in LUSC identified key TFs including KLF5 and MYC in basal cells (Supplementary Fig. 3a), consistent with its amplification and overexpression in lung cancer patients, acting as the prognostic markers of early-stage tumors.29,31